CTX310
CRSP-CVD-400
Phase 1 small_molecule active
Quick answer
CTX310 for Cardiovascular is a Phase 1 program (small_molecule) at CRISPR Therapeutics AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CRISPR Therapeutics AG
- Indication
- Cardiovascular
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active